UNSPSC 51372113: Codeine hydrochloride

This classification denotes an opiate with the molecular formula C18H21NO3.ClH.2H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier NTZ53GG7XN, chemically known as morphinan-6-alpha-ol, 7,8-didehydro-4,5-alpha-epoxy-3-methoxy-17-methyl-, hydrochloride but more generally known as codeine hydrochloride, which bears US NIH Compound Identifier 5359615. European Medicines Agency schedules Codeine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01405MIG.

Most nations, for tariff and trade purposes, schedule codeine hydrochloride under HS 29391100. As of Q4 2014, CODEINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. SMILES: CN1CC[C@]23C4C5CCC(C4O[C@H]2[C@H](C=C[C@H]3[C@H]1C5)O)OC.O.O.CL.

UNSPSC 51372113 Codeine hydrochloride is a Commodity code representing a single pharmaceutical product line, but recent state and local procurement activity under this code does not reflect codeine-specific purchases. Instead, jurisdictions are soliciting broader pharmaceutical and medication-access products—naloxone for overdose response, drug deactivation systems, and generic multi-source pharmaceuticals through cooperative purchasing frameworks. The work spans pharmaceutical procurement, supply chain management, and community health support, with vendors required to meet FDA compliance, cGMP certification, Drug Supply Chain Security Act adherence, insurance requirements, and federal regulatory obligations when FEMA funding is involved.

Issuing bodies include county health departments (Seminole County, Florida), state health and human services agencies (Texas HHS Commission), and multi-state cooperative purchasing organizations (Minnesota Multistate Cooperative Purchasing Alliance serving state and local government facilities across multiple states including Oregon). Recent opportunities show a mix of direct county procurement and cooperative-vehicle acquisitions. The geographic spread covers Florida, Texas, Minnesota, and Oregon, with activity also extending across participating MMCAP jurisdictions. Representative recent solicitations include Seminole County's IFB60459723LAS (posted June 30, 2026, response deadline July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries; Texas HHS's RFI HHS0017013 (posted April 3, 2026) exploring direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager arrangements; and MMCAP's S1070000015802 (posted January 20, 2026, response deadline March 26, 2026) for generic multi-source pharmaceuticals and OTC products through three authorized wholesalers with a July 1, 2026 contract effective date. The code shows limited direct codeine solicitation activity; pursuit should focus on the broader pharmaceutical supply ecosystem rather than codeine-specific opportunities.